From July 1, 2022 to September 30, 2022, the company has repurchased 844,600 shares, representing 0.14% for CNY 38.16 million. With this, the company has completed the repurchase of 5,260,910 shares, representing 0.9% for CNY 243.27 million under the buyback announced on March 19, 2022.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
54.28 CNY | +2.03% | +0.37% | -4.79% |
Apr. 19 | Autobio Diagnostics' Q1 Profit Jumps 34% | MT |
Apr. 19 | Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.79% | 4.35B | |
-1.04% | 12.55B | |
-17.29% | 7.02B | |
-2.21% | 5.19B | |
+2.92% | 4.37B | |
-50.07% | 3.33B | |
+7.65% | 2.62B | |
-15.92% | 2.03B | |
-3.34% | 1.67B | |
-13.66% | 1.45B |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.